Conclusion: An inflection point in weight management The loss of exclusivity for semaglutide in 2026 marks a strategic turning point in how players operate within the evolving AOM market
Sources Novo Nordisk , Wegovy once-weekly semaglutide injection factsheet
Reusing them introduces contamination risk into both the vial and the injection
If your plan covers Zepbound, there may be some specific requirements you should meet, such as: Shop Medications , You have to meet the FDAs requirements for Zepbound, which include being an adult who is at least 18 years old and above, having a body mass index (BMI) of 30 or higher or a BMI of 27 or higher, with at least one weight-related condition such as type 2 diabetes (T2DM), cardiovascular disease, hypertension (high blood pressure), or obstructive sleep apnea
How To Get an Ozempic Prescription: Who Is Eligible
Hypothyroidism: When thyroid hormones are low, metabolism slows dramatically
